Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Novartis reports new clinical data showing benefits of Ultibro Breezhaler

Novartis reports new clinical data showing benefits of Ultibro Breezhaler

5th September 2016

Novartis has announced new clinical trial data showing the benefits its Ultibro Breezhaler therapy can offer in the treatment of chronic obstructive pulmonary disease (COPD).

New analyses from the head-to-head FLAME study have been presented at the European Respiratory Society's international congress in London, showing that Ultibro Breezhaler is a more effective option for patients at risk of COPD exacerbations than an established alternative.

Ultibro Breezhaler demonstrated consistent reductions in the rate of all exacerbations, regardless of the age, smoking status, exacerbation history, disease severity, eosinophil levels and previous inhaled corticosteroid usage status of the patients.

Those with the most severe forms of COPD saw a significant reduction in the rate of exacerbations and were able to improve their health status, while the Novartis therapy was also associated with a reduced need for rescue medication during the day.

Vasant Narasimhan, global head drug development and chief medical officer for Novartis, said: "These new analyses of the data show the consistency of these findings across different patient subgroups, including a post-hoc analysis in those previously using a triple therapy containing an ICS."

Ultibro Breezhaler is currently approved for use in over 90 countries worldwide, including nations within the EU.

With? ?over? ?20? ?years? ?of? ?experience? ?within? ?the? ?pharmaceutical? ?market,? ?we? ?at? ?Zenopa? ?have? ?the knowledge,? ?skills? ?and? ?expertise? ?to? ?help? ?find? ?the? ?right? ?job? ?for? ?you.? ?To? ?find? ?out? ?more? ?about? ?the current? ?pharmaceutical? ?roles? ?we? ?have? ?available,? ?you? ?can? ?search? ?for? ?the? ?latest? ?job? ?roles, register? ?your? ?details,? ?or? ?contact? ?the? ?team? ?today.ADNFCR-8000103-ID-801824719-ADNFCR

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.